What is Alpha Tau Medical Ltd (DRTS) stock price today?

Alpha Tau Medical Ltd (DRTS) currently trades at $7.37 per share. The stock has a market capitalization of $712.00M and a P/E ratio of —x.

Is DRTS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Alpha Tau Medical Ltd has a Smart Value Score of 17/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 2/9 and Altman Z-Score is -1.64.

Is Alpha Tau Medical Ltd financially healthy?

Alpha Tau Medical Ltd's Piotroski F-Score is 2/9 (weak financial health). The Altman Z-Score of -1.64 places it in the distress.

DRTS

Alpha Tau Medical Ltd

NASDAQ: DRTS · HEALTHCARE · BIOTECHNOLOGY

$7.37

+0.96% today

Updated 2026-04-29

Market cap

$712.00M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.53

Dividend yield

—

52W range

$3 – $9

Volume

0.3M

Market cap

$712.00M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.53

Dividend yield

—

52W range

$3 – $9

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-1.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$9.50

+28.90%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.17x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -1.64 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-32.76M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-33.76M	$-29.16M	$-31.75M	$-42.63M	$-12.14M
EPS	—	—	—	—	$-0.53
Free cash flow	$-24.78M	$-24.36M	$-22.02M	$-32.76M	$-32.76M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
DRTS	$712.00M	17	4.3	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Alpha Tau Medical Ltd trades at $7.37. Our Smart Value Score of 17/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -1.64, it sits in the distress.

Frequently asked questions

What is Alpha Tau Medical Ltd's stock price?

Alpha Tau Medical Ltd (DRTS) trades at $7.37.

Is Alpha Tau Medical Ltd overvalued?

Smart Value Score 17/100 (Grade F, Strong Sell).

What is the price target of Alpha Tau Medical Ltd (DRTS)?

The analyst target price is $9.50, representing +28.9% upside from the current price of $7.37.

Piotroski F-Score?

2/9 — weak financial health.

Altman Z-Score?

-1.64 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.alphatau.com

Quick metrics

P/S ratio—

ROE-61.00%

Beta1.05

50D MA$7.34

200D MA$5.14

Shares out0.09B

Float0.05B

Short ratio—

Avg volume0.3M

Performance

1 week-7.64%

1 month+4.24%

3 months+1.80%

YTD+48.89%

1 year—

3 years—

5 years—

Compare

DRTS vs LLY →DRTS vs JNJ →DRTS vs ABBV →Stock screener →